Global Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Nicotinamide Mononucleotide (NMN) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Nicotinamide mononucleotide (NMN) is an intermediate of NAD+ biosynthesis produced from nicotinamide through nicotinamide phosphoribosyltransferase (NAMPT) and also referred to as NMN or nicotinamide ribotide. In recent studies of NMN applications to prevention and diagnosis of age-dependent diseases such as diabetes, neurodegenerative disorder, cardiac disease etc., it has become one of hottest biomarkers on discussion for anti-aging, lately.

According to our (Global Info Research) latest study, the global Nicotinamide Mononucleotide (NMN) market size was valued at US$ 371 million in 2023 and is forecast to a readjusted size of USD 774 million by 2030 with a CAGR of 10.6% during review period.

Core manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Mirarailab Bioscience, Maac10 Formulas, Herbalmax and Genex Formula. China is the largest production region, accounting for approximately 64% of the global market, followed by Japan and North America. In terms of product type, products with content ≥98% are the largest market segment, with a share of more than 99%. In terms of product application, the largest application market is health care products, with a share of approximately 99%.

This report is a detailed and comprehensive analysis for global Nicotinamide Mononucleotide (NMN) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Nicotinamide Mononucleotide (NMN) market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030

Global Nicotinamide Mononucleotide (NMN) market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030

Global Nicotinamide Mononucleotide (NMN) market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Kg), 2019-2030

Global Nicotinamide Mononucleotide (NMN) market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Kg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Nicotinamide Mononucleotide (NMN)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Nicotinamide Mononucleotide (NMN) market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneHarbor, Herbalmax, Genex Formulas, Mirailab Bioscience, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Nicotinamide Mononucleotide (NMN) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Content ≥98%
Content ＜98%

Market segment by Application
Health Care Products
Cosmetics
Others

Major players covered
GeneHarbor
Herbalmax
Genex Formulas
Mirailab Bioscience
Maac10 Formulas
EffePharm
Bontac
CELFULL
Kingdomway

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Nicotinamide Mononucleotide (NMN) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Nicotinamide Mononucleotide (NMN), with price, sales quantity, revenue, and global market share of Nicotinamide Mononucleotide (NMN) from 2019 to 2024.

Chapter 3, the Nicotinamide Mononucleotide (NMN) competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Nicotinamide Mononucleotide (NMN) breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Nicotinamide Mononucleotide (NMN) market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Nicotinamide Mononucleotide (NMN).

Chapter 14 and 15, to describe Nicotinamide Mononucleotide (NMN) sales channel, distributors, customers, research findings and conclusion.